Global Pharmaceutical & Biotechnology Environmental Monitoring Market Research Report 2022

Market Analysis and Insights: Global Pharmaceutical & Biotechnology Environmental Monitoring Market
Environmental monitoring during pharmaceutical and biopharmaceutical production is crucial for ensuring the safety of formulated drug products. While requirements for the control of both viable (living microorganisms) and non-viable particles (e.g. dust, hair, etc.) and other contaminants (i.e. trace metals, volatiles, etc.) for aseptic manufacturing operations are more extensive than those for non-sterile processes, the quantity of samples that must be analyzed and the amount of data generated can be daunting regardless of the final drug form, particularly for global companies with multiple production facilities.

This report studies the Pharmaceutical & Biotechnology Environmental Monitoring market. It covered Monitoring Equipment, Media, Reagents & Kits, Microbiology Services, Environmental Monitoring and Software used in Pharmaceutical & Biotechnology Environmental Monitoring.
The global Pharmaceutical & Biotechnology Environmental Monitoring market size is projected to reach US$ 1411.4 million by 2028, from US$ 940.4 million in 2021, at a CAGR of 5.9% during 2022-2028.
Danaher Corporation, Thermo Fisher Scientific, Merck KGAA, Eurofins Sinensis and Lonza are the leading productors of Pharmaceutical & Biotechnology Environmental Monitoring. The top three accounted for about 20% of the total market.
North America is the largest market, accounting for about 40%. Europe is next with about 25%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical & Biotechnology Environmental Monitoring market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical & Biotechnology Environmental Monitoring market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical & Biotechnology Environmental Monitoring market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical & Biotechnology Environmental Monitoring market.
Global Pharmaceutical & Biotechnology Environmental Monitoring Scope and Market Size
Pharmaceutical & Biotechnology Environmental Monitoring market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pharmaceutical & Biotechnology Environmental Monitoring market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Monitoring Equipment
Media
Software
Microbiology Services
Segment by Application
Pharmaceutical Industry
Biotechnology Industry
Academic & Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Danaher Corporation
Thermo Fisher Scientific
Merck KGaA
Eurofins Sinensis
Lonza
Biomerieux
VAI
Cosasco
RMONI
Amphenol Advanced Sensors
Vaisala